ENRASENTAN EDAMINE
UNII W4N3HUS9UW

Substance Identification & Data

This profile provides standardized clinical and technical data for Enrasentan Edamine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) W4N3HUS9UW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 183507-63-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

W4N3HUS9UW

CAS Registry Number

183507-63-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ENRASENTAN EDAMINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

2C29H30O8.C2H8N2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WWCIKXJATPIKHK-HTFWYUNBSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C223717

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

15886604

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@@H]1(c2c([C@H]([C@@H]1C(=O)O)c3c(cc(cc3)OC)OCCO)cc(OCCC)cc2)c4cc5c(cc4)OCO5.NCCN.[C@@H]1(c2c([C@H]([C@@H]1C(=O)O)c3c(cc(cc3)OC)OCCO)cc(OCCC)cc2)c4cc5c(cc4)OCO5

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Enrasentan Edamine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

1H-INDENE-2-CARBOXYLIC ACID, 1-(1,3-BENZODIOXOL-5-YL)-2,3-DIHYDRO-3-(2-(2-HYDROXYETHOXY)-4-METHOXYPHENYL)-5-PROPOXY-, (1S-(1.ALPHA.,2.BETA.,3.ALPHA.))-, COMPD. WITH 1,2-ETHANEDIAMINE (2:1)

1H-INDENE-2-CARBOXYLIC ACID, 1-(1,3-BENZODIOXOL-5-YL)-2,3-DIHYDRO-3-(2-(2-HYDROXYETHOXY)-4-METHOXYPHENYL)-5-PROPOXY-, (1S,2R,3S)-, COMPD. WITH 1,2-ETHANEDIAMINE (2:1)

ENRASENTAN EDAMINE

External Clinical & Regulatory Resources

Previous UNIIW4M79L3ZB0

Next UNIIW4N6E1T46B